Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Management of non-neurogenic male lower urinary tract symptoms should be personalized and patient-centered, rather than based on a stepwise approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.eururo.2025.06.010 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tamsulosin for Urinary Retention in Older Women: Maximizing the Flow.
J Gerontol Nurs
September 2025
Albany College of Pharmacy and Health Sciences, Albany, New York.
Purpose: Urinary retention (UR) is a lower urinary tract symptom (LUTS) that can present in men and women aged ≥65 years. However, unlike the medications available for men to treat this condition, the current approach to management of chronic UR in women is limited to conservative methods and urinary catheterization, which have various risks. The current article reviews the use of tamsulosin as a potential pharmacological alternative for the management of chronic UR in older women.
View Article and Find Full Text PDFA Randomized Non-Inferiority Trial for Telemedicine in the Follow-Up of Overactive Bladder Patients.
Neurourol Urodyn
September 2025
Department of Urology, Division of Pelvic Medicine & Reconstructive Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Purpose: Despite the increasing use of telemedicine in Urology, regulatory barriers and lack of care-team training have limited its imprint on healthcare delivery. We designed a non-inferiority trial to delineate the use-case of telemedicine in the management of overactive bladder. This prospective, randomized controlled trial aims to validate the telemedicine paradigm as a feasible alternative to traditional in-person clinic visits, evaluating effectiveness, patient satisfaction, safety, and cost metrics.
View Article and Find Full Text PDFDecision-making algorithm for difficult intermittent self-catheterization: construction and validation using the Delphi method.
World J Urol
July 2025
Sorbonne University, GRC 01, GREEN Group of clinical REsEarch in Neurourology, AP-HP, Hôpital Pitié Salpêtrière, Paris, 75013, France.
Purpose: Intermittent Self Catheterization (ISC) is the gold standard for chronic neurogenic and non neurogenic urinary retention. However, difficulties encountered may lead to poor adherence and discontinuation. This study aimed to develop and validate a decision-making algorithm to guide first and second line management of the more common difficulties reported by patients performing ISC.
View Article and Find Full Text PDFManagement of Non-neurogenic Male Lower Urinary Tract Symptoms: Better Holistic than Sequential.
Eur Urol
September 2025
Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Management of non-neurogenic male lower urinary tract symptoms should be personalized and patient-centered, rather than based on a stepwise approach.
View Article and Find Full Text PDFClinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treating Neurogenic and Non-Neurogenic Voiding Dysfunctions Due to Bladder Neck Dysfunction.
Toxins (Basel)
June 2025
Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan.
Bladder neck dysfunction (BND) is a pathophysiology associated with voiding dysfunction in patients with neurogenic or non-neurogenic voiding dysfunction. Botulinum toxin A (BoNT-A) injection is a minimally invasive alternative for treating bladder outlet dysfunction; however, its efficacy for BND has not been well established. In this retrospective study, 41 patients with videourodynamic study-confirmed BND who failed medical therapy received a transurethral bladder neck injection of 100-U BoNT-A.
View Article and Find Full Text PDF